Comments
Roche confirms outlook as Q3 tops forecasts
16.10.2012. | ZURICH (Reuters) - Swiss drugmaker Roche Holding AG confirmed its full-year outlook on Tuesday, as a weaker Swiss franc and strong sales of its top-selling cancer medicines offset declines in other drugs in the third quarter....
